3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lung Neoplasms
4
Glioma
3
Glioblastoma
3
Breast Neoplasms
3
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Osteoradionecrosis
1
Neurotoxicity Syndromes
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematopoietic and Lymphoid System Neoplasm
1
Ependymoma
1
Cytokine Release Syndrome
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
siltuximab
4
fludarabine
3
Cyclophosphamide
3
fludarabine phosphate
2
Interleukin 1 Receptor Antagonist Protein
2
AP 1903 reagent
2
tocilizumab
1
talquetamab
1
axicabtagene ciloleucel
1
Neuropsychological Tests
1
Metoprolol
1
Magnetic Resonance Spectroscopy
1
Leukapheresis
1
Infliximab
1
Etanercept
1
Dexamethasone
1
Contrast Media
1
Calcium Dobesilate
1
Blood Specimen Collection
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cytokine Release Syndrome
×
Contrast Media
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled